Survival, durable response, and long-term safety in patients with previously treated advanced renal cell carcinoma receiving nivolumab

David F. McDermott*, Toni K. Choueiri, Igor Puzanov, Stephen Hodi, Charles G. Drake, Julie R. Brahmer, Hans J. Hammers, Suzanne L. Topalian, Drew M. Pardoll, Mario Sznol, John D. Powderly, David C. Smith, Richard D. Carvajal, Jon M. Wigginton, Georgia D. Kollia, Ashok Gupta, Dan McDonald, Vindira Sankar, Jeffrey A. Sosman, Michael B. Atkins

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

334 Scopus citations

Fingerprint

Dive into the research topics of 'Survival, durable response, and long-term safety in patients with previously treated advanced renal cell carcinoma receiving nivolumab'. Together they form a unique fingerprint.

Medicine & Life Sciences